🇺🇸 FDA
Pipeline program

Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion

INFLUENCE

Phase 3 small_molecule active

Quick answer

Fludarabine phosphate 25 mg/ml Concentrate for Solution for Injection or Infusion for B-cell Acute Lymphoblastic Leukemia is a Phase 3 program (small_molecule) at AXIM BIOTECHNOLOGIES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
AXIM BIOTECHNOLOGIES, INC.
Indication
B-cell Acute Lymphoblastic Leukemia
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials